New agreement between Novartis and the NHS enables broad and rapid access to cholestrol lowering medicine ‘Inclisiran’. In December 2019, an in-principle agreement was made…
View More New approaches to Lipid managementNew agreement between Novartis and the NHS enables broad and rapid access to cholestrol lowering medicine ‘Inclisiran’. In December 2019, an in-principle agreement was made…
View More New approaches to Lipid management